ARCHIVES

FDA Guidance for Public Comment at Advisory Committee Meetings

This article is from The Cancer Letter archive.

Vol. 36 No. 45 | December 10, 2010

Download PDF Visit The Full Archive

Related Articles

Analyzing Tumor Tissue In Clinical Trials Can Improve Outcomes, RTOG Trial Finds

May 27, 2011

Has The Pendulum Swing too Far Toward Grants? NCI, NCAB Ponder Best Way to Stimulate Work In New areas

December 5, 1980

Evidence Supports Screening Younger Women, Expert Says

September 24, 1993

NCI Bid For New Clinical Review Panel Rejects; But Invites Researchers To ‘Submit Best Ideas’

March 8, 1991

NCI CTEP-Approved Trials For the Month of November

November 28, 2014

NCI, ACS, Health Departments Launch ASSIST, Goal To Cut US Smoking Rate In Half By Yr 2000

October 11, 1991